MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013 Read more
Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access Read more
BMS and Compugen Announce Clinical Collaboration to Evaluate Therapeutic Regimen in Advanced Solid Tumors Read more
ROSLINCT and REPROCELL awarded £1.2 million project from Innovate UK for clinical-grade stem cell production Read more
Mundipharma Strengthens Position as a Leader in Biosimilars with Acquisition of Development Company Cinfa Biotech Read more